Compugen Ltd

Затворен

2.43 -2.02

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.42

Максимум

2.48

Ключови измерители

By Trading Economics

Приходи

663K

-7M

Продажби

426K

2.6M

P/E

Средно за сектора

6.526

56.432

EPS

-0.07

Марж на печалбата

-269.254

Служители

75

EBITDA

665K

-7M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+100.8% upside

Дивиденти

By Acuity

Следващи печалби

9.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

9.8M

235M

Предишно отваряне

4.45

Предишно затваряне

2.43

Compugen Ltd Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.09.2026 г., 23:56 ч. UTC

Revvity Inc is trading modestly higher in after-market hours, positioned above its 20-day moving average and near the upper end of its one-month range.

21.09.2026 г., 23:56 ч. UTC

Correlated Moves

Eversource Energy is advancing in after-market hours, influenced by OGE Energy's gains earlier in the session, though it remains below its 20-day moving average.

21.09.2026 г., 23:56 ч. UTC

Owens Corning is trading modestly higher in after-market hours, recovering from a recent trend of six consecutive sessions ending lower.

21.09.2026 г., 23:56 ч. UTC

Ameriprise Financial Inc is trading slightly higher in after-market hours, recovering from an earlier dip but remains below its 20-day moving average.

21.09.2026 г., 23:56 ч. UTC

Pool Corp is trading modestly higher in after-market hours following a decline in the Chicago Fed National Activity Index for August, reflecting slower economic growth.

21.09.2026 г., 23:55 ч. UTC

Chimera Investment Corp is trading roughly flat in after-market hours, about 2.48% below its 20-day moving average.

21.09.2026 г., 23:55 ч. UTC

Lamb Weston Holdings Inc is trading modestly lower in after-market hours, continuing the earlier session's weakness and remaining below its 20-day moving average.

21.09.2026 г., 23:55 ч. UTC

Ziff Davis Inc declined during after-market hours on Monday, influenced by broader economic slowdown signals, despite remaining above its 20-day moving average.

21.09.2026 г., 23:55 ч. UTC

Old Republic International Corp is trading modestly higher in after-market hours, recovering slightly after a series of declines over the previous five sessions.

21.09.2026 г., 23:55 ч. UTC

Carlyle Group Inc is trading modestly lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

21.09.2026 г., 23:55 ч. UTC

Mitek Systems Inc is up in after-market trading, reaching a peak despite remaining below its 20-day moving average amid slowing economic growth signals.

21.09.2026 г., 23:55 ч. UTC

Truist Financial Corp is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

21.09.2026 г., 23:55 ч. UTC

Darling Ingredients Inc's stock is trading modestly higher in after-market hours, despite a decline in the Chicago Fed National Activity Index for August.

21.09.2026 г., 23:55 ч. UTC

Solaredge Technologies Inc is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

21.09.2026 г., 23:55 ч. UTC

Booking Holdings Inc. is trading modestly higher in after-market hours following Monday's close, despite remaining significantly below its 20-day moving average.

21.09.2026 г., 23:55 ч. UTC

OraSure Technologies Inc. is trading modestly higher in after-market hours, marking its eighth consecutive session of gains while remaining above its 20-day moving average.

21.09.2026 г., 23:55 ч. UTC

Revolve Group Inc. is trading roughly flat in after-market hours, fluctuating within a range amid economic growth concerns from the Chicago Fed National Activity Index.

21.09.2026 г., 23:52 ч. UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

21.09.2026 г., 23:52 ч. UTC

Yelp Inc. is declining in after-market trading, remaining significantly below its 20-day moving average and continuing a trend of lower daily closes.

21.09.2026 г., 23:51 ч. UTC

Cathay General Bancorp is trading modestly higher in after-market hours, recovering from a slight dip and reaching a peak cumulative return of nearly 1%.

21.09.2026 г., 23:51 ч. UTC

Janus International Group Inc has advanced modestly in after-market trading, continuing a pattern of strength observed throughout the session.

21.09.2026 г., 23:51 ч. UTC

CoStar Group Inc rebounded in after-market trading, showing a cumulative return above its prior close despite remaining below its 20-day moving average.

21.09.2026 г., 23:51 ч. UTC

Cooper Companies Inc is trading modestly higher during after-market hours, despite a significant decline over the past month and trading below its 20-day moving average.

21.09.2026 г., 23:51 ч. UTC

Social Media

Rocket Lab Corp's stock rises in after-market trading following Cantor Fitzgerald's bullish note, reiterating a $122 price target amid successful launches and an upcoming acquisition.

21.09.2026 г., 23:51 ч. UTC

Cabaletta Bio Inc saw notable gains in after-market trading, recovering from a low return shortly after the market closed to a higher return by late session.

21.09.2026 г., 23:51 ч. UTC

Molson Coors Beverage Co sees a modest increase in after-market trading, reaching its highest cumulative return since Monday's close, despite being below its 20-day moving average.

21.09.2026 г., 23:51 ч. UTC

Allstate Corp is seeing notable upward movement in after-market trading, recovering from six consecutive sessions of lower finishes.

21.09.2026 г., 23:51 ч. UTC

CRISPR Therapeutics AG is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

21.09.2026 г., 23:51 ч. UTC

OGE Energy Corp is trading modestly higher in after-market hours, following notable upward movement from its previous close, despite remaining below its 20-day moving average.

21.09.2026 г., 23:51 ч. UTC

United Therapeutics Corp is trading modestly higher in after-market hours, recovering from an initial dip and showing volatility since Monday's close.

Сравнение с други в отрасъла

Ценова промяна

Compugen Ltd Прогноза

Ценова цел

By TipRanks

100.8% нагоре

12-месечна прогноза

Среден 5 USD  100.8%

Висок 6 USD

Нисък 4 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Compugen Ltd през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

2

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.